Results 141 to 150 of about 14,850 (194)

Efficacy and safety of sacubitril/valsartan combined with dapagliflozin in non-diabetic patients with advanced chronic kidney disease. [PDF]

Front Endocrinol (Lausanne)
Wang H, Li X, Jiang C, Liu X.
europepmc   +1 more source

Comparison of the Efficacy of Empagliflozin, Dapagliflozin, and Allopurinol Based on Serum Uric Acid Levels and Kidney Function in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study. [PDF]

Med Sci (Basel)
Fejes R, Jámbor T, Lantos T, Tallósy SP.   +3 more
europepmc   +1 more source

Dapagliflozin mitigates myocardial inflammation and metabolic stress in heart failure through STAT1 inhibition: Evidence from multi-omics analyses and experimental exploration. [PDF]

PLoS One
He L, Zhang D, Zhang S, Ren Z, Huangfu Y, Cheng X, Song Z.   +6 more
europepmc   +1 more source

Effects of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors on Lipid Profiles in Type 2 Diabetes: A Systematic Review. [PDF]

Cureus
Abdalla M, Khamees MES, Gehani AL, Ibrahim AIM, Yousif MY, Kheir N, Mohammed Qasem Alqasem S, Ahmed A.   +7 more
europepmc   +1 more source

Dapagliflozin in Patients With CKD With Fabry Disease. [PDF]

Kidney Int Rep
Battaglia Y, Vitturi N, Marchi G, Baciga F, Caccia F, Gugelmo G, Martinetti L, Stefanelli LF, Torresani S, Pisani A, Riccio E, Esposito P, Viazzi F, Chimenti C, Martino FK, Lenzini L, Sechi A, Zanoli L, Girelli D, Fadini GP, Nalesso F, Carraro G.   +21 more
europepmc   +1 more source

From Glucose Transport to Microbial Modulation: The Impact of Sodium Glucose Co-Transporter-2 Inhibitors on the Gut Microbiota. [PDF]

Med Sci (Basel)
George MY, Gamal NK, Safwat K, Mamdouh M, AbdElFatah A, Atallah A, Cerchione C.   +6 more
europepmc   +1 more source

SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies. [PDF]

Drug Des Devel Ther
Su H, Li X, Wang S, Yang X, Jiang L, Luo H, Li Y, Zhou J, Huang Y, Li M.   +9 more
europepmc   +1 more source

Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial. [PDF]

High Blood Press Cardiovasc Prev
Russo E, Cappadona F, Macciò L, Di Vincenzo J, Piaggio M, Verzola D, Chirco G, Garibotto G, Esposito P, Viazzi F.   +9 more
europepmc   +1 more source

Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching. [PDF]

PLoS One
Yuan Z, Jeffcoat CH, Ali SR, Sena AG, Schuemie MJ, Ryan PB, Fonseca SA.   +6 more
europepmc   +1 more source